Startup Funding Tracker
Home›People›Kristina Burow
KB

Kristina Burow

Director and 10% owner at Boundless Bio. Also a director at Treeline Biosciences, Metsera and Mirador Therapeutics.

DirectorPublic companyRoles at 4 startups
Updated Nov 9, 2026·Latest SEC filing Jul 6, 2026·Suggest an edit

About Kristina Burow

Kristina Burow is a director and 10% owner at Boundless Bio.

Form D filings also name Kristina Burow as a director at Treeline Biosciences, Metsera and Mirador Therapeutics.

Kristina Burow reports to the SEC as a director or major shareholder of 21 public companies, including Scholar Rock Holding (SRRK), Kardigan (KARD) and Neumora Therapeutics (NMRA).

Kristina Burow first appears on SEC filings in 2013.

Experience

This experience comes from SEC filings. The years are when the filings name Kristina Burow in the role, so the role may have started earlier or lasted longer.

Boundless Bio, Inc.
Director and 10% owner
2020 – 2026 · Public company (BOLD)
Scholar Rock Holding Corp
Director and 10% owner
2018 – 2026 · Public company (SRRK)
Kardigan, Inc.
Director and 10% owner
2026 · Public company (KARD)
Neumora Therapeutics, Inc.
Director and 10% owner
2023 – 2026 · Public company (NMRA)
Seaport Therapeutics, Inc.
10% owner
2026 · Public company (SPTX)
Lyell Immunopharma, Inc.
10% owner
2025 – 2026 · Public company (LYEL)
Metsera, Inc.
Director and 10% owner
2024 – 2025 · Public company (MTSR)
Treeline Biosciences, Inc.
Director
2021 – 2025 · Watertown, MA
Prime Medicine, Inc.
10% owner
2022 – 2025 · Public company (PRME)
Maze Therapeutics, Inc.
10% owner
2025 · Public company (MAZE)
Rapport Therapeutics, Inc.
10% owner
2024 · Public company (RAPP)
Mirador Therapeutics, Inc.
Director
2024 · San Diego, CA
Sana Biotechnology, Inc.
10% owner
2021 – 2024 · Public company (SANA)
DA32 Life Science Tech Acquisition Corp.
10% owner
2021 – 2023 · Public company (DALS)
Gossamer Bio, Inc.
Director
2019 – 2023 · Public company (GOSS)
Beam Therapeutics Inc.
Director
2020 – 2023 · Public company (BEAM)
Erasca, Inc.
10% owner
2021 · Public company (ERAS)
Unity Biotechnology, Inc.
Director
2018 – 2021 · Public company (UBX)
Verve Therapeutics, Inc.
10% owner
2021 · Public company (VERV)
Metacrine, Inc.
Director
2020 – 2021 · Public company (MTCR)
Vir Biotechnology, Inc.
Director
2019 – 2020 · Public company (VIR)
Sienna Biopharmaceuticals, Inc.
Director and 10% owner
2017 – 2019 · Public company (SNNA)
Receptos, Inc.
Director
2013 – 2015 · Public company (RCPT)

Key Colleagues at Startups

The people Kristina Burow works with at each company, as listed on that company's latest Form D.

Treeline Biosciences, Inc. · Form D, Sep 4, 2025
SE
Steven Elms
Director
DB
David Bonita
Director
JB
Joshua Bilenker
Executive officer, director and promoter
JE
Jeffrey Engelman
Executive officer, director and promoter
AK
AS
Ali Satvat
Director
Avi Naider
Avi Naider
Director
DS
Metsera, Inc. · Form D, Nov 20, 2024
CV
Christopher Visioli
Executive officer
BH
Brian Hubbard
Executive officer
CB
Christopher Bernard
Chief Executive Officer and director
SM
Steven Marso
Executive officer
CM
PB
Paul Berns
Director
JP
Joshua Pinto
Director
Mirador Therapeutics, Inc. · Form D, Apr 3, 2024
PB
Paul Berns
Director
JP
Joseph Papa
Director
MM
Mark McKenna
Executive officer and director
SG
Scott Glenn
Director
VB
Vika Brough
Executive officer
DD
TA
Boundless Bio, Inc. · Form D, Aug 15, 2023
ZH
Zachary Hornby
CEO, President, and Director
BD
FD
JD
JL
Jennifer Lew
Director
CD
JD

Sources

  1. SECTreeline Biosciences, Inc. Form D, filed Sep 4, 2025
  2. SECMetsera, Inc. Form D, filed Nov 20, 2024
  3. SECMirador Therapeutics, Inc. Form D, filed Apr 3, 2024
  4. SECBoundless Bio, Inc. Form D, filed Aug 15, 2023
  5. SECForms 3, 4 and 5 filed by Kristina Burow (SEC filer 1569248)